Antihyperglycemic activities of twig extract of indigenous cinnamon (Cinnamomum osmophloeum) on high-fat diet and streptozotocin-induced hyperglycemic rats

Journal of the Science of Food and Agriculture

Volumn 98, Issue 15, 2018, Pages 5908-5915

  Lin, Gong Min ^a   Hsu, Chia Yun ^a   Chang, Shang Tzen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

amylase; antihyperglycemic activity; Cinnamomum osmophloeum; disaccharidases; lipase; proanthocyanidins

Indexed keywords

ANTIDIABETIC AGENT; PLANT EXTRACT; PROANTHOCYANIDIN; STREPTOZOCIN;

ANIMAL; CHEMISTRY; CINNAMOMUM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LIPID DIET; MALE; METABOLISM; RAT;

ANIMALS; BLOOD GLUCOSE; CINNAMOMUM; DIET, HIGH-FAT; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; PLANT EXTRACTS; PROANTHOCYANIDINS; RATS; STREPTOZOCIN;

EID: 85052918043     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.9286     Document Type: Article

References (38)

1. International Diabetes Federation, IDF Diabetes Atlas, 8th edn., 2017. [Online]. Available: http://www.idf.org/membership/mena/pakistan [18 December 2017].
2. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 37:S81–S90 (2014).
3. Cappuccio FP, D'Elia L, Strazzullo P and Miller MA, Quantity and quality of sleep and incidence of type 2 diabetes. Diabetes Care 33:414–420 (2010).
4. Vázquez-Vela MEF, Torres N and Tovar AR, White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 3:715–728 (2008).
5. Harwood HJ, The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 6:57–75 (2012).
6. Stern JH, Rutkowski JM and Scherer PE, Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab 23:770–784 (2016).
7. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K and Tobe K, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792 (2006).
8. Liu L, Yu YL, Liu C, Wang XT, Liu XD and Xie L, Insulin deficiency induces abnormal increase in intestinal disaccharidase activities and expression under diabetic states, evidences from in vivo and in vitro study. Biochem Pharmacol 82:1963–1970 (2011).
9. Adachi T, Mori C, Sakurai K, Shihara N, Tsuda K and Yasuda K, Morphological changes and increased sucrase and isomaltase activity in small intestines of insulin-deficient and type 2 diabetic rats. Endocr J 50:271–279 (2003).
10. Tormo MA, Martinez IM, de Tejada AR, Gil-Exojo I and Campillo JE, Morphological and enzymatic changes of the small intestine in an n0-STZ diabetes rat model. Exp Clin Endocrinol Diabetes 110:119–123 (2002).
11. Wu YHS, Chiu CH, Yang DJ, Lin YL, Tseng JK and Chen YC, Inhibitory effects of litchi (Litchi chinensis Sonn.) flower-water extracts on lipase activity and diet-induced obesity. J Funct Foods 5:923–929 (2013).
12. Bösenberg LH and Van Zyl DG, The mechanism of action of oral antidiabetic drugs: a review of recent literature. JEMDSA 13:80–88 (2008).
13. Birari RB and Bhutani KK, Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discovery Today 12:879–889 (2007).
14. Kang JG and Park CY, Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 36:13–25 (2012).
15. Chang CLT, Lin Y, Bartolome AP, Chen YC, Chiu SC and Yang WC, Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid-Based Complementary Altern Med 2013:37865733 (2013).
16. Adisakwattana S, Lerdsuwankij O, Poputtachai U, Minipun A and Suparpprom C, Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Plant Foods Hum Nutr 66:143–148 (2011).
17. Lin GM, Chen YH, Yen PL and Chang ST, Antihyperglycemic and antioxidant activities of twig extract from Cinnamomum osmophloeum. J Tradit Complementary Med 6:281–288 (2016).
18. Lin GM, Lin HY, Hsu CY and Chang ST, Structural characterization and bioactivity of proanthocyanidins from indigenous cinnamon (Cinnamomum osmophloeum). J Sci Food Agric 96:4749–4759 (2016).
19. Shihabudeen HMS, Priscilla DH and Thirumurugan K, Cinnamon extract inhibits α-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr Metab 8:46 (2011).
20. Beejmohun V, Peytavy-Izard M, Mignon C, Muscente-Paque D, Deplanque X, Ripoll C et al., Acute effect of Ceylon cinnamon extract on postprandial glycemia: alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers. BMC Complement Altern Med 14:351 (2014).
21. Veerapur VP, Prabhakar KR, Thippeswamy BS, Bansal P, Srinivasan KK and Unnikrishnan MK, Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats: a mechanistic study. Food Chem 132:186–193 (2012).
22. Jurgoński A, Juśkiewicz J and Zduńczyk Z, Ingestion of black chokeberry fruit extract leads to intestinal and systemic changes in a rat model of prediabetes and hyperlipidemia. Plant Food Hum Nutr 63:176–182 (2008).
23. Dahlqvist A, Assay of intestinal disaccharidases. Anal Biochem 22:99–107 (1968).
24. Bartoli E, Fra GP and Schianca GPC, The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med 22:8–12 (2011).
25. Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC and Sharma A, β-Cell growth and regeneration: replication is only part of the story. Diabetes 59:2340–2348 (2010).
26. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R et al., Impaired fasting glucose and impaired glucose tolerance. Diabetes Care 30:753–759 (2007).
27. Patil SB, Ghadyale VA, Taklikar SS, Kulkarni CR and Arvindekar AU, Insulin secretagogue, alpha-glucosidase and antioxidant activity of some selected spices in streptozotocin-induced diabetic rats. Plant Food Hum Nutr 66:85–90 (2011).
28. Ismail NS, Protective effects of aqueous extracts of cinnamon and ginger herbs against obesity and diabetes in obese diabetic rat. World J Dairy Food Sci 9:145–153 (2014).
29. Vítek L, The role of bilirubinin diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol 3:1–7 (2012).
30. 10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 4:89–98 (2010).
31. Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C and Herz M, Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study. Lancet 374:126–135 (2009).
32. Qin B, Dawson HD, Schoene NW, Polansky MM and Anderson RA, Cinnamon polyphenols regulate multiple metabolic pathways involved in insulin signaling and intestinal lipoprotein metabolism of small intestinal enterocytes. Nutrition 28:1172–1179 (2012).
33. Liu L, Deng Y, Yu S, Lu S, Xie L and Liu X, Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats. Pharmazie 63:384–388 (2008).
34. De la Iglesia R, Milagro FI, Campión J, Boqué N and Martínez JA, Healthy properties of proanthocyanidins. Biofactors 36:159–168 (2010).
35. Ou K and Gu L, Absorption and metabolism of proanthocyanidins. J Funct Food 7:43–53 (2014).
36. Mateos-Martín ML, Fuguet E, Quero C, Pérez-Jiménez J and Torres JL, New identification of proanthocyanidins in cinnamon (Cinnamomum zeylanicum L.) using MALDI-TOF/TOF mass spectrometry. Anal Bioanal Chem 402:1327–1336 (2012).
37. Mateos-Martín ML, Pérez-Jiménez J, Fuguet E and Torres JL, Profile of urinary and fecal proanthocyanidin metabolites from common cinnamon (Cinnamomum zeylanicum L.) in rats. Mol Nutr Food Res 56:671–675 (2012).
38. Ge ZZ, Dong XQ, Zhu W, Zhang Y and Li CM, Metabolites and changes in antioxidant activity of A-type and B-type proanthocyanidin dimers after incubation with rat intestinal microbiota. J Agric Food Chem 63:8991–8998 (2015).